Independent Prescribing in Community Pharmacy: What Changes From Autumn 2026
One of the most significant parts of the 2026/27 community pharmacy settlement in England is the introduction of NHS-funded independent prescribing in community pharmacy. From autumn 2026, pharmacist prescribers will be able to treat more conditions directly, rather than referring patients back to a GP.
What is changing
Independent prescribing is being added as an extension of Pharmacy First and the Pharmacy Contraception Service. The Department of Health and Social Care has said that community pharmacist prescribers will be able to offer up to five new prescribing-only Pharmacy First pathways.
Why it matters
Patients get faster access to treatment for common conditions.
Pressure on GP appointments is reduced.
Pharmacies gain new clinical services and income streams.
What pharmacies need to prepare
Qualified prescribers, or a plan to train existing pharmacists.
Consultation space and clinical governance processes.
Reliable access to the medicines the new pathways will require, at the volumes patients will need.
The supply angle
New prescribing pathways mean new demand patterns. Pharmacies that offer these services will need stock they can count on, often at short notice. Building that supply resilience now, through a mix of main and secondary wholesalers, will make the transition smoother. Acorn Pharmaceuticals is ready to support pharmacies as they expand their clinical offer.
Talk to Acorn Pharmaceuticals: email gb@acornpharmaceuticals.co.uk or message us on WhatsApp.
Comments